Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-24 Tax Withholding | 2024-02-27 5:11 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 40,272 | $1.13 | 2,552,204 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 4:39 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 2,000,000 | $0 | 2,592,476 (Direct) | View |
| 2023-11-25 Tax Withholding | 2023-11-28 4:19 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director | 10,411 | $0.3821 | 592,476 (Direct) | View |
| 2023-08-25 Tax Withholding | 2023-08-29 4:13 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director | 10,411 | $0.77 | 602,887 (Direct) | View |
| 2023-05-25 Tax Withholding | 2023-05-30 4:40 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director | 10,411 | $1.33 | 613,298 (Direct) | View |
| 2023-02-24 Option Award | 2023-03-06 5:06 pm | N/A 2033-02-23 | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director | 891,350 | $0 | 1,357,759 (Direct) | View |
| 2023-02-25 Tax Withholding | 2023-03-06 5:06 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director | 54,767 | $2.66 | 1,357,759 (Direct) | View |
| 2022-02-25 Option Award | 2022-03-01 5:16 pm | N/A 2032-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director | 828,800 | $0 | 1,125,976 (Direct) | View |
| 2022-02-25 Tax Withholding | 2022-03-01 5:16 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director | 49,890 | $5.9 | 1,125,976 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 9:08 pm | N/A 2031-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President and CEO | 415,125 | $0 | 623,816 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-03-01 9:08 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President and CEO | 35,311 | $11.19 | 623,816 (Direct) | View |
| 2021-01-24 Tax Withholding | 2021-01-26 8:24 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President and CEO | 3,977 | $14.95 | 244,002 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-26 7:29 pm | N/A 2030-02-24 | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President and CEO | 506,250 | $0 | 585,479 (Direct) | View |
| 2020-02-25 Tax Withholding | 2020-02-26 7:29 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President and CEO | 7,264 | $6.8 | 585,479 (Direct) | View |
| 2020-01-24 Tax Withholding | 2020-01-28 7:11 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President and CEO | 4,283 | $7.5 | 86,493 (Direct) | View |